Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome

Y. Shoenfeld, I. Krause, F. Kvapil, J. Sulkes, S. Lev, P. Von Landenberg, J. Font, J. Zaech, R. Cervera, J. C. Piette, M. C. Boffa, M. A. Khamashta, M. L. Bertolaccini, G. R V Hughes, P. Youinou, P. L. Meroni, V. Pengo, J. D. Alves, A. Tincani, G. SzegediG. Lakos, G. Sturfelt, A. Jönsen, T. Koike, M. Sanmarco, A. Ruffatti, Z. Ulcova-Gallova, S. Praprotnik, B. Rozman, M. Lorber, V. B. Vriezman, M. Blank

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Two-hundred ninety five patients with the antiphospholipid syndrome (APS) were studied for the presence of antibodies against six anti-β2GPI-related peptides Abs. The prevalence of a wide spectrum of clinical and laboratory parameters of APS was evaluated in all patients, and correlated with the presence of each anti-β2GPI peptide antibody. The rates of the various antipeptides Abs ranged from 18.0 to 63.7%. Altogether, 87.1% of the patients had antibody reactivity against at least one of the six β2GPI-related peptides. A high degree of simultaneous reactivity against several β2GPI-peptides was found. Positive and negative correlations were found between several antipeptides Abs and the rates of thrombosis and fetal loss. Our results point to a heterogeneous activity of antiphospholipid Abs in APS patients, directed, often concurrently, against various epitopes of the β2GPI molecule. Evaluation of APS patients for the presence of specific antipeptides Abs may be of a value in predicting the risk for future thrombotic and obstetrical complication, as well as for specific therapeutic purposes.

Original languageEnglish
Pages (from-to)377-383
Number of pages7
JournalJournal of Clinical Immunology
Volume23
Issue number5
DOIs
Publication statusPublished - Sep 2003

Fingerprint

Antiphospholipid Syndrome
Glycoproteins
Peptides
Antibodies
Epitopes
Thrombosis

Keywords

  • Antiphospholipid syndrome
  • Autoimmunity
  • Synthetic peptides
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome. / Shoenfeld, Y.; Krause, I.; Kvapil, F.; Sulkes, J.; Lev, S.; Von Landenberg, P.; Font, J.; Zaech, J.; Cervera, R.; Piette, J. C.; Boffa, M. C.; Khamashta, M. A.; Bertolaccini, M. L.; Hughes, G. R V; Youinou, P.; Meroni, P. L.; Pengo, V.; Alves, J. D.; Tincani, A.; Szegedi, G.; Lakos, G.; Sturfelt, G.; Jönsen, A.; Koike, T.; Sanmarco, M.; Ruffatti, A.; Ulcova-Gallova, Z.; Praprotnik, S.; Rozman, B.; Lorber, M.; Vriezman, V. B.; Blank, M.

In: Journal of Clinical Immunology, Vol. 23, No. 5, 09.2003, p. 377-383.

Research output: Contribution to journalArticle

Shoenfeld, Y, Krause, I, Kvapil, F, Sulkes, J, Lev, S, Von Landenberg, P, Font, J, Zaech, J, Cervera, R, Piette, JC, Boffa, MC, Khamashta, MA, Bertolaccini, ML, Hughes, GRV, Youinou, P, Meroni, PL, Pengo, V, Alves, JD, Tincani, A, Szegedi, G, Lakos, G, Sturfelt, G, Jönsen, A, Koike, T, Sanmarco, M, Ruffatti, A, Ulcova-Gallova, Z, Praprotnik, S, Rozman, B, Lorber, M, Vriezman, VB & Blank, M 2003, 'Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome', Journal of Clinical Immunology, vol. 23, no. 5, pp. 377-383. https://doi.org/10.1023/A:1025321617304
Shoenfeld, Y. ; Krause, I. ; Kvapil, F. ; Sulkes, J. ; Lev, S. ; Von Landenberg, P. ; Font, J. ; Zaech, J. ; Cervera, R. ; Piette, J. C. ; Boffa, M. C. ; Khamashta, M. A. ; Bertolaccini, M. L. ; Hughes, G. R V ; Youinou, P. ; Meroni, P. L. ; Pengo, V. ; Alves, J. D. ; Tincani, A. ; Szegedi, G. ; Lakos, G. ; Sturfelt, G. ; Jönsen, A. ; Koike, T. ; Sanmarco, M. ; Ruffatti, A. ; Ulcova-Gallova, Z. ; Praprotnik, S. ; Rozman, B. ; Lorber, M. ; Vriezman, V. B. ; Blank, M. / Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome. In: Journal of Clinical Immunology. 2003 ; Vol. 23, No. 5. pp. 377-383.
@article{ab4ae59c700d4d7aaa3d21fb1313de66,
title = "Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome",
abstract = "Two-hundred ninety five patients with the antiphospholipid syndrome (APS) were studied for the presence of antibodies against six anti-β2GPI-related peptides Abs. The prevalence of a wide spectrum of clinical and laboratory parameters of APS was evaluated in all patients, and correlated with the presence of each anti-β2GPI peptide antibody. The rates of the various antipeptides Abs ranged from 18.0 to 63.7{\%}. Altogether, 87.1{\%} of the patients had antibody reactivity against at least one of the six β2GPI-related peptides. A high degree of simultaneous reactivity against several β2GPI-peptides was found. Positive and negative correlations were found between several antipeptides Abs and the rates of thrombosis and fetal loss. Our results point to a heterogeneous activity of antiphospholipid Abs in APS patients, directed, often concurrently, against various epitopes of the β2GPI molecule. Evaluation of APS patients for the presence of specific antipeptides Abs may be of a value in predicting the risk for future thrombotic and obstetrical complication, as well as for specific therapeutic purposes.",
keywords = "Antiphospholipid syndrome, Autoimmunity, Synthetic peptides, Systemic lupus erythematosus",
author = "Y. Shoenfeld and I. Krause and F. Kvapil and J. Sulkes and S. Lev and {Von Landenberg}, P. and J. Font and J. Zaech and R. Cervera and Piette, {J. C.} and Boffa, {M. C.} and Khamashta, {M. A.} and Bertolaccini, {M. L.} and Hughes, {G. R V} and P. Youinou and Meroni, {P. L.} and V. Pengo and Alves, {J. D.} and A. Tincani and G. Szegedi and G. Lakos and G. Sturfelt and A. J{\"o}nsen and T. Koike and M. Sanmarco and A. Ruffatti and Z. Ulcova-Gallova and S. Praprotnik and B. Rozman and M. Lorber and Vriezman, {V. B.} and M. Blank",
year = "2003",
month = "9",
doi = "10.1023/A:1025321617304",
language = "English",
volume = "23",
pages = "377--383",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome

AU - Shoenfeld, Y.

AU - Krause, I.

AU - Kvapil, F.

AU - Sulkes, J.

AU - Lev, S.

AU - Von Landenberg, P.

AU - Font, J.

AU - Zaech, J.

AU - Cervera, R.

AU - Piette, J. C.

AU - Boffa, M. C.

AU - Khamashta, M. A.

AU - Bertolaccini, M. L.

AU - Hughes, G. R V

AU - Youinou, P.

AU - Meroni, P. L.

AU - Pengo, V.

AU - Alves, J. D.

AU - Tincani, A.

AU - Szegedi, G.

AU - Lakos, G.

AU - Sturfelt, G.

AU - Jönsen, A.

AU - Koike, T.

AU - Sanmarco, M.

AU - Ruffatti, A.

AU - Ulcova-Gallova, Z.

AU - Praprotnik, S.

AU - Rozman, B.

AU - Lorber, M.

AU - Vriezman, V. B.

AU - Blank, M.

PY - 2003/9

Y1 - 2003/9

N2 - Two-hundred ninety five patients with the antiphospholipid syndrome (APS) were studied for the presence of antibodies against six anti-β2GPI-related peptides Abs. The prevalence of a wide spectrum of clinical and laboratory parameters of APS was evaluated in all patients, and correlated with the presence of each anti-β2GPI peptide antibody. The rates of the various antipeptides Abs ranged from 18.0 to 63.7%. Altogether, 87.1% of the patients had antibody reactivity against at least one of the six β2GPI-related peptides. A high degree of simultaneous reactivity against several β2GPI-peptides was found. Positive and negative correlations were found between several antipeptides Abs and the rates of thrombosis and fetal loss. Our results point to a heterogeneous activity of antiphospholipid Abs in APS patients, directed, often concurrently, against various epitopes of the β2GPI molecule. Evaluation of APS patients for the presence of specific antipeptides Abs may be of a value in predicting the risk for future thrombotic and obstetrical complication, as well as for specific therapeutic purposes.

AB - Two-hundred ninety five patients with the antiphospholipid syndrome (APS) were studied for the presence of antibodies against six anti-β2GPI-related peptides Abs. The prevalence of a wide spectrum of clinical and laboratory parameters of APS was evaluated in all patients, and correlated with the presence of each anti-β2GPI peptide antibody. The rates of the various antipeptides Abs ranged from 18.0 to 63.7%. Altogether, 87.1% of the patients had antibody reactivity against at least one of the six β2GPI-related peptides. A high degree of simultaneous reactivity against several β2GPI-peptides was found. Positive and negative correlations were found between several antipeptides Abs and the rates of thrombosis and fetal loss. Our results point to a heterogeneous activity of antiphospholipid Abs in APS patients, directed, often concurrently, against various epitopes of the β2GPI molecule. Evaluation of APS patients for the presence of specific antipeptides Abs may be of a value in predicting the risk for future thrombotic and obstetrical complication, as well as for specific therapeutic purposes.

KW - Antiphospholipid syndrome

KW - Autoimmunity

KW - Synthetic peptides

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0042832999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042832999&partnerID=8YFLogxK

U2 - 10.1023/A:1025321617304

DO - 10.1023/A:1025321617304

M3 - Article

C2 - 14601646

AN - SCOPUS:0042832999

VL - 23

SP - 377

EP - 383

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 5

ER -